Accession Number: | 0001562180-21-004397 |
Date: | 2021-06-17 |
Issuer: | G1 THERAPEUTICS, INC. (GTHX) |
Original Submission Date: |
SCHWALM CYNTHIA
700 PARK OFFICES DRIVE, SUITE 200
RESEARCH TRIANGLE PARK, NC 27709
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-17 | A | 4,389 | a | $0.00 | 5,889 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS (RIGHT TO BUY) | 21.97 | 2021-06-17 | deemed execution date | A | 19,620 (a) | 2031-06-17 | common stock 19,620 | $21.97 | 19,620 | direct |
ID | footnote |
---|---|
f1 | represents a restricted stock unit ("rsu") award that vests in its entirety twelve months after june 17, 2021, subject to the reporting person's continued service as a director. |
f2 | each rsu represents a contingent right to receive one share of issuer common stock |
f3 | represents 1,500 shares of common stock and 4,389 restricted stock units |
f4 | the shares underlying this option will vest in their entirety twelve months after june 17, 2021, subject to the reporting person's continued service as a director. |